Soon Ha Kim

This inventor holds 11 USPTO granted patents and 11 published patent applications and 6 EPO patents. Top assignees: Lg Life Sciences, Limited, Lg Chem, Ltd. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soon Ha Kim. Retrieved from https://idiyas.com/inventor/soon-ha-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 11)

% Patents Active = 100.0

EPO Patents = 6 (Patent Applications = 16)

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 6(Granted Patents)

Company Filing History:

7 out of 75

Lg Life Sciences, Limited

Years Active: 2012-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10927097 - Indole compound as inhibitor of necrosis (2021-02-23),

2. 10322135 - Pharmaceutical composition comprising indole compound (2019-06-18),

3. 9868731 - Indole amide compound as inhibitor of necrosis (2018-01-16),

4. 9814726 - Composition for preventing or treating fatty liver diseases (2017-11-14),

5. 9000028 - Indole and indazole compounds as an inhibitor of cellular necrosis (2015-04-07),

6. 8889691 - Indole compounds as an inhibitor of cellular necrosis (2014-11-18),

7. 8569307 - Indole compounds as an inhibitor of cellular necrosis (2013-10-29),

8. 8436038 - Indole and indazole compounds as an inhibitor of cellular necrosis (2013-05-07),

9. 8349885 - Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect (2013-01-08),

10. 8309586 - Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient (2012-11-13),

11. 8222414 - Indole compounds as an inhibitor of cellular necrosis (2012-07-17),

Title: Biography of Inventor Soon Ha Kim

Introduction: Soon Ha Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various medical conditions.

Latest Patents: Soon Ha Kim holds a total of 11 patents. His latest patents include an indole compound as an inhibitor of necrosis, which relates to a composition for the prevention or treatment of necrosis and necrosis-associated diseases. Another notable patent is a pharmaceutical composition comprising an indole compound for the prevention or treatment of diseases associated with oxidative stress, mitochondrial dysfunction, hypoxic injury, necrosis, and ischemic reperfusion injury.

Career Highlights: Throughout his career, Soon Ha Kim has worked with notable companies such as LG Life Sciences and LG Chem. His work has focused on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations: He has collaborated with esteemed colleagues, including Hyoung Jin Kim and Heui Sul Park, to further enhance the impact of his research and inventions.

Conclusion: Soon Ha Kim's dedication to innovation in pharmaceuticals has led to significant advancements in the treatment of various diseases. His work continues to influence the field and improve patient outcomes.

Profile summary based on public USPTO records.